Cervical Cerclage for Singleton Pregnant on Vaginal Progesterone With Progressive Cervical Length Shortening
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of this study is to Determine whether cerclage with vaginal progesterone will:
- 1.Reduce the overall spontaneous preterm birth rate.
- 2.Prolong pregnancy latency.
- 3.Improve neonatal outcome. Compared to vaginal progesterone only, in patients with progressive cervical shortening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2019
CompletedFirst Posted
Study publicly available on registry
February 12, 2019
CompletedStudy Start
First participant enrolled
April 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 22, 2019
CompletedFebruary 12, 2019
February 1, 2019
5 months
January 8, 2019
February 9, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gestational age of delivery
After 37 weeks of pregnancy
<37 weeks
Secondary Outcomes (1)
New born birth weight
At time of birth
Study Arms (2)
Vaginal progesterone only
NO INTERVENTIONcontinue on vaginal progesterone only
Cervical cerclage plus vaginal progesterone
EXPERIMENTALcerclage with vaginal progesterone.
Interventions
Cervical cerclage under effect of spinal anaesthesia
Eligibility Criteria
You may qualify if:
- Women aged: 20-38 years old.
- Single living fetus.
- The patient does not have history of preterm labor (before 37 weeks of gestation)
- No history of cervical or uterine anomalies.
You may not qualify if:
- Congenital anomalies in the fetus discovered during the follow up.
- History of spontaneous preterm births.
- Evidence of imminent delivery, or uterine contractions.
- Evidence of rupture of membranes, or intra amniotic infection.
- Intra uterine fetal death.
- Uterine or cervical anomalies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AinshamsU
Cairo, +02, Egypt
Related Publications (1)
Eleje GU, Eke AC, Ikechebelu JI, Ezebialu IU, Okam PC, Ilika CP. Cervical stitch (cerclage) in combination with other treatments for preventing spontaneous preterm birth in singleton pregnancies. Cochrane Database Syst Rev. 2020 Sep 24;9(9):CD012871. doi: 10.1002/14651858.CD012871.pub2.
PMID: 32970845DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yasser Shahawy
Ain Shams University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle invistigator
Study Record Dates
First Submitted
January 8, 2019
First Posted
February 12, 2019
Study Start
April 22, 2019
Primary Completion
September 20, 2019
Study Completion
October 22, 2019
Last Updated
February 12, 2019
Record last verified: 2019-02